Genetic determinants of COVID-19 severity and mortality: ACE1 Alu 287 bp polymorphism and ACE1 , ACE2 , TMPRSS2 expression in hospitalized patients
PeerJ · 2025
DOI: 10.7717/peerj.18508 ↗Kurz gefasst
Fachartikel in der Zeitschrift PeerJ, 2025. Verfasst von João Locke Ferreira de Araújo und 19 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de genética, ecologia e evolução, Laboratório de biologia integrativa, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerai…. Hauptthemen laut MEDLINE: COVID-19, Serine Endopeptidases, Angiotensin-Converting Enzyme 2, Peptidyl-Dipeptidase A. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rede Corona-ômica BR MCTI/FINEP affiliated with RedeVírus/MCTI, Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES.
Abstract (Originalsprache)
Background
The angiotensin-converting enzyme 2 (ACE2) and the transmembrane serine protease 2 (TMPRSS2) are central human molecules in the SARS-CoV-2 virus-host interaction. Evidence indicates that ACE1 may influence ACE2 expression. This study aims to determine whether ACE1, ACE2, and TMPRSS2 mRNA expression levels, along with the ACE1 Alu 287 bp polymorphism ( rs4646994 ), contribute to the severity and mortality of COVID-19.
Methods
Swabs were collected in two Brazilian cities in 2020: Belo Horizonte ( n = 134) and Rio de Janeiro ( n = 41). A swab of mild patients in Rio de Janeiro who were not hospitalized ( n = 172) was also collected. All analyzed biological material was obtained from residual diagnostic samples in 2020, prior to the emergence of SARS-CoV-2 variants of concern. ACE1 , ACE2 , TMPRSS2, and B2M (reference gene) expression levels were evaluated in 40 cycles of quantitative PCR. ACE1 Alu 287 bp polymorphism was genotyped using the FastStart Universal SYBR Green Master kit.
Results
The median age differed between clinical sites ( p = 0.016), but no difference in median days of hospitalization was observed ( p = 0.329). Age was associated with severity ( p = 0.014) and mortality ( p = 0.014) in the Belo Horizonte cohort. No alteration in ACE1 , ACE2 and TMPRSS2 expression was associated with severity or mortality. ACE1 polymorphism rs4646994 did not influence the likelihood of either outcome. A meta-analysis including available data from the literature showed significant effects: the D-allele conferred risk (OR = 1.39; 95% CI [1.12–1.72]).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de genética, ecologia e evolução, Laboratório de biologia integrativa, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
- Departamento de biorregulação, Laboratório de imunofarmacologia e biologia molecular, Universidade Federal da Bahia, Salvador, BA, Brazil.
- Departamento de genética, Laboratório de Virologia Molecular, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Núcleo de Enfrentamento e Estudos de Doenças Infecciosas Emergentes e Reemergentes (NEEDIER), Universidade Federal do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil.
- Hospital Eduardo de Menezes, Belo Horizonte, Minas Gerais, Brazil.
- Marinha do Brasil, Instituto de Pesquisas Biomédicas, Hospital Naval Marcilio Dias, Rio de Janeiro, Rio de Janeiro, Brazil.
Förderung
- Rede Corona-ômica BR MCTI/FINEP affiliated with RedeVírus/MCTI
- Conselho Nacional de Desenvolvimento Científico e Tecnológico - CNPq
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
- Financiadora de Estudos e Projetos - FINEP
- Fundação de Apoio à Pesquisa do Rio de Janeiro - FAPERJ
Zitieren
APA
de Araújo, J. L. F., Rossi, Á. D., de Almeida, J. M., Alves, H. J., Leitão, I. C., de Ávila, R. E., Castiñeiras, A. C. P., Oliveira, J. D. S., Galliez, R. M., Tonini, M. D. L., Faffe, D. S., Barroso, S. P. C. B., Resende, G. G., Gonçalves, C. C. A., Castiñeiras, T. M. P. P., Tanuri, A., Teixeira, M. M., Aguiar, R. S., Cardoso, C. C., & de Souza, R. P. (2025). Genetic determinants of COVID-19 severity and mortality: ACE1 Alu 287 bp polymorphism and ACE1 , ACE2 , TMPRSS2 expression in hospitalized patients. PeerJ. https://doi.org/10.7717/peerj.18508
Vancouver
de Araújo JLF, Rossi ÁD, de Almeida JM, Alves HJ, Leitão IC, de Ávila RE, et al. Genetic determinants of COVID-19 severity and mortality: ACE1 Alu 287 bp polymorphism and ACE1 , ACE2 , TMPRSS2 expression in hospitalized patients. PeerJ. 2025. doi:10.7717/peerj.18508
BibTeX
@article{deArajo2025,
author = {de Araújo, João Locke Ferreira and Rossi, Átila Duque and de Almeida, Jessica Maciel and Alves, Hugo José and Leitão, Isabela de Carvalho and de Ávila, Renata Eliane and Castiñeiras, Anna Carla Pinto and Oliveira, Jéssica da Silva and Galliez, Rafael Mello and Tonini, Marlon Daniel Lima and Faffe, Débora Souza and Barroso, Shana Priscila Coutinho Barroso and Resende, Gustavo Gomes and Gonçalves, Cássia Cristina Alves and Castiñeiras, Terezinha Marta Pereira Pinto and Tanuri, Amilcar and Teixeira, Mauro Martins and Aguiar, Renato Santana and Cardoso, Cynthia Chester and de Souza, Renan Pedra},
title = {Genetic determinants of COVID-19 severity and mortality: ACE1 Alu 287 bp polymorphism and ACE1 , ACE2 , TMPRSS2 expression in hospitalized patients},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.18508}
}
EUVIMED